These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10413244)

  • 1. The comparative arthropathy of fluoroquinolones in dogs.
    Takizawa T; Hashimoto K; Minami T; Yamashita S; Owen K
    Hum Exp Toxicol; 1999 Jun; 18(6):392-9. PubMed ID: 10413244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats.
    Takizawa T; Hasimoto K; Itoh N; Yamashita S; Owen K
    Hum Exp Toxicol; 1999 Jan; 18(1):38-45. PubMed ID: 10025367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics.
    Förster C; Schwabe R; Lozo E; Zippel U; Vormann J; Günther T; Merker HJ; Stahlmann R
    Arch Toxicol; 1997; 72(1):26-32. PubMed ID: 9458187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.
    Nagai A; Miyazaki M; Morita T; Furubo S; Kizawa K; Fukumoto H; Sanzen T; Hayakawa H; Kawamura Y
    J Toxicol Sci; 2002 Aug; 27(3):219-28. PubMed ID: 12238145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
    Linseman DA; Hampton LA; Branstetter DG
    Fundam Appl Toxicol; 1995 Nov; 28(1):59-64. PubMed ID: 8566484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones.
    Shakibaei M; Baumann-Wilschke I; Rücker M; Stahlmann R
    Arch Toxicol; 2002 Jan; 75(11-12):725-33. PubMed ID: 11876506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
    Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
    Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic disposition and arthropathic potential of oral ofloxacin in dogs.
    Yoshida K; Yabe K; Nishida S; Yamamoto N; Ohshima C; Sekiguchi M; Yamada K; Furuhama K
    J Vet Pharmacol Ther; 1998 Apr; 21(2):128-32. PubMed ID: 9597650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early pathophysiologic feature of arthropathy in juvenile dogs induced by ofloxacin, a quinolone antimicrobial agent.
    Yabe K; Satoh H; Ishii Y; Jindo T; Sugawara T; Furuhama K; Goryo M; Okada K
    Vet Pathol; 2004 Nov; 41(6):673-81. PubMed ID: 15557076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period.
    von Keutz E; Rühl-Fehlert C; Drommer W; Rosenbruch M
    Arch Toxicol; 2004 Jul; 78(7):418-24. PubMed ID: 15014927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats.
    Kappel EM; Shakibaei M; Bello A; Stahlmann R
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3320-2. PubMed ID: 12234871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondrotoxicity of ciprofloxacin in immature beagle dogs: immunohistochemistry, electron microscopy and drug plasma concentrations.
    Stahlmann R; Kühner S; Shakibaei M; Schwabe R; Flores J; Evander SA; van Sickle DC
    Arch Toxicol; 2000 Jan; 73(10-11):564-72. PubMed ID: 10663388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative grepafloxacin phototoxicity in mouse skin.
    Owen K
    J Antimicrob Chemother; 1998 Aug; 42(2):261-4. PubMed ID: 9738848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profile of grepafloxacin compared with other fluoroquinolones.
    Stahlmann R; Schwabe R
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():83-92. PubMed ID: 9484877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL; Fuchs PC
    J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of grepafloxacin, ciprofloxacin, and theophylline in human plasma and urine by HPLC.
    Kamberi M; Hajime N; Kamberi P; Uemura N; Nakamura K; Nakano S
    Ther Drug Monit; 1999 Jun; 21(3):335-40. PubMed ID: 10365649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of quinolone-induced arthropathy in juvenile dogs by use of magnetic resonance (MR) imaging.
    Yabe K; Yoshida K; Yamamoto N; Nishida S; Ohshima C; Sekiguchi M; Yamada K; Furuhama K
    J Vet Med Sci; 1997 Jul; 59(7):597-9. PubMed ID: 9271457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-arthropathic dose and its disposition following repeated oral administration of ofloxacin, a new quinolone antimicrobial agent, to juvenile dogs.
    Yabe K; Murakami Y; Nishida S; Sekiguchi M; Furuham K; Goryo M; Okada K
    J Vet Med Sci; 2001 Aug; 63(8):867-72. PubMed ID: 11558541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grepafloxacin.
    Wagstaff AJ; Balfour JA
    Drugs; 1997 May; 53(5):817-24; discussion 825-7. PubMed ID: 9129868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.